EMA – Open consultation: Addendum to the Guideline on clinical development of vaccines to address clinical trials in immunocompromised individuals
This Addendum to the guideline provides guidance on clinical studies to be conducted in immunocompromised individuals before or after initial marketing authorization of vaccines in order to support recommendations for use in the Product Information. The deadline for the consultation is 31 October 2024. More open consultations on the EMA Website.
Publication Details
- Journal
- Industrias Culturais (Universidade de Coimbra)
- Published
- 2024-10-19
- DOI
- https://doi.org/10.58079/12j9t
- Primary Topic
- Immune responses and vaccinations
- Type
- article
- Field-Weighted Citation Impact
- 0.00